Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02300987
Title A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

germ cell cancer

Therapies

Ribociclib

Age Groups: adult
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
USC Kenneth Norris Comprehensive Cancer Center Oncology Dept Los Angeles California 90033 United States Details
New Mexico Cancer Care Alliance Albuquerque New Mexico 87106 United States Details
Memorial Sloan Kettering Oncology Department. New York New York 10017 United States Details
Novartis Investigative Site Villejuif Cedex 94800 France Details
Novartis Investigative Site Groningen 9713 GZ Netherlands Details
Novartis Investigative Site Hospitalet de LLobregat Catalunya 08907 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field